GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Pre-Tax Income

Aarey Drugs & Pharmaceuticals (BOM:524412) Pre-Tax Income : ₹53 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Aarey Drugs & Pharmaceuticals's pretax income for the three months ended in Mar. 2024 was ₹21 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹53 Mil. Aarey Drugs & Pharmaceuticals's pretax margin was 1.02%.

During the past 13 years, Aarey Drugs & Pharmaceuticals's highest Pretax Margin was 2.53%. The lowest was 0.66%. And the median was 2.03%.


Aarey Drugs & Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Pre-Tax Income Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.42 83.01 100.37 60.10 53.43

Aarey Drugs & Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.40 7.25 10.07 14.65 21.46

Competitive Comparison of Aarey Drugs & Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarey Drugs & Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Pre-Tax Income falls into.



Aarey Drugs & Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Aarey Drugs & Pharmaceuticals's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=27.533+0+-43.753+0+69.649
=53

Aarey Drugs & Pharmaceuticals's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-18.381+0+-11.545+0+51.388
=21

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarey Drugs & Pharmaceuticals  (BOM:524412) Pre-Tax Income Explanation

Aarey Drugs & Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=21.462/2103.54
=1.02%

During the past 13 years, Aarey Drugs & Pharmaceuticals's highest Pretax Margin was 2.53%. The lowest was 0.66%. And the median was 2.03%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarey Drugs & Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarey Drugs & Pharmaceuticals (BOM:524412) Business Description

Traded in Other Exchanges
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (BOM:524412) Headlines

No Headlines